TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study.

Matthew H Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.